Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-0509
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models ; volume:7 ; number:3 ; day:16 ; month:10 ; year:2013 ; pages:1-11 ; date:10.2013
BMC systems biology ; 7, Heft 3 (16.10.2013), 1-11, 10.2013
- Urheber
-
Yoshida, Kenta
- Beteiligte Personen und Organisationen
-
Maeda, Kazuya
Kusuhara, Hiroyuki
Konagaya, Akihiko
SpringerLink (Online service)
- DOI
-
10.1186/1752-0509-7-S3-S3
- URN
-
urn:nbn:de:1111-201607303437
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yoshida, Kenta
- Maeda, Kazuya
- Kusuhara, Hiroyuki
- Konagaya, Akihiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat